Product class: Authorized package
Medicinal product class: For human use
Package code: 1633384
Name of medicinal product: ABILIFY MAINTENA
Active substances:
Estonian, English, Latin
ATC code: N05AX12
Dosage form: powder and solvent for prolonged-release suspension for injection
Route of administration: intramuscular use
Strengh: 400mg
Amount in package: 3TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information: lahusti 2 ml
Indication: ABILIFY MAINTENA is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Otsuka Pharmaceutical Netherlands B.V. 
Marketing authorization number: EU/1/13/882 
Marketing authorization issued on: 15 November 2013 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: 18 October 2018
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription